China-US M&A

China-US M&A deals meet mixed reviews

US company Medtronic plans to buy China’s KangHui Medical that makes orthopaedic implants, while Chinese wind company Ralls Corp is ordered to divest its interest in a US wind farm due to national security.

<div style="text-align: left;"> Medtronic's Beijing patient care centre </div>

Lara Wozniak

October 03, 2012

Before the long weekend holiday in Hong Kong and China last week, Minneapolis-based Medtronic agreed to pay $816 million for China’s KangHui Medical, which makes implants to treat orthopaedic conditions. It is a bid to win a piece of the pie in China’s healthcare market.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.